UC Regents Innovation Awards | | From left to right: Kevan Shokat, PhD, winner of the Gamechanger Award; Joseph DeRisi, PhD, winner of the Best Startup Award; Susan Lynch, PhD, winner of the Disruptive Research Award; and Steven Hauser, MD, winner of the Distinguished Lifetime Achievement Award. | |
UCSF Wins Big, From Gamechangers
to Startups to Life Achievement
UC is a worldwide leader in discovery, as the No. 1 public university for academic research with the most influential scientists and a world record for Nobel prizes.
And with the world’s most startups and most patented inventions, no other university does more to transform discoveries into real-world solutions that generate jobs, grow the economy and make life better for everyone.
The winners of the inaugural UC Regents Innovation Awards exemplify UC’s real-world impact. Announced this week, the awards honor 23 people in five categories, chosen from a group of nominees representing all 10 UC campuses and three affiliated national labs.
| | |
“The Board is honored to support University of California innovators who turn discoveries into new jobs, economic growth, and lasting societal benefit across the country.”
UC Board of Regents Chair Maria Anguiano.
| | Presented at a dinner at the UCLA Luskin Conference Center, Kevan Shokat, PhD, won the 'Gamechanger Award'; Joseph DeRisi, PhD, won the 'Best Startup Award'; Susan Lynch, PhD, won the 'Disruptive Research Award'; and Steven Hauser, MD, won the 'Distinguished Lifetime Achievement Award.' | | |
UCSF honors four extraordinary leaders with the UCSF Medal, the university’s most prestigious award, for their groundbreaking contributions to advancing science, patient care, and public health — and their enduring commitment to improving lives around the world.
| | | | |
Jeffrey Bluestone, PhD
Jeffrey Bluestone has transformed our understanding of the immune system and translated scientific discoveries into breakthrough therapies.
A longtime UCSF professor and leader, his pioneering research in immune tolerance has advanced immunotherapies for autoimmune disease, organ transplantation, and cancer, including the first FDA-approved treatment to delay the onset of type 1 diabetes.
Watch
| | | |
Sue Desmond-Hellmann,
MD, MPH
Sue Desmond-Hellmann is a physician-scientist whose leadership has advanced human health across biotechnology, academic medicine, and global health. Throughout her career in industry and nonprofits, including as UCSF’s first female chancellor, she has brought people together to tackle complex challenges and improve lives.
Watch
| | | | | |
Julie Louise Gerberding, MD, MPH
A pioneering leader in public health and infectious disease, Julie Gerberding has brought people and disciplines together to tackle some of the world’s most complex health challenges. A UCSF alumna and former faculty member, she became the first woman to lead the CDC, guiding the agency through SARS, anthrax bioterrorism, and other emerging public health crises.
Watch
| | | |
Ambassador Eric Goosby, MD
Eric Goosby has devoted his career to transforming HIV/AIDS care and advancing health worldwide. An internationally recognized infectious disease expert and UCSF professor, he helped pioneer San Francisco’s model of HIV care, led the Ryan White CARE Act program, and oversaw the expansion of PEPFAR, bringing lifesaving treatment to millions of people around the globe and aggressively moving countries toward elimination of pediatric HIV.
Watch
| | | |
QB3 Early-Stage Mentoring
for Biotech Startups
| | |
QB3 (the multicampus UC institute supporting innovation in bioscience) offers support programs for entrepreneurial bioscientists who want to commercialize their research.
The QB3 mentoring program matches you 1:1 with mentors who have deep experience with bio startups and who want to help you move your technology forward.
Need help with IP matters, indication selection/market fit, or fundraising?
| | | | |
